切换至 "中华医学电子期刊资源库"
高级检索
中华介入放射学电子杂志

中华介入放射学电子杂志 ›› 2019, Vol. 07 ›› Issue (03) : 202 -205. doi: 10.3877/cma.j.issn.2095-5782.2019.03.006

所属专题： 文献；

专题研究·肿瘤介入

超选择性肾动脉栓塞术治疗肾癌性血尿的效果观察
王晓雨1, 吴常生2, 闫瑞强2, 张磊2, 刘海艳2, 穆永旭2,†()   
  1. 1. 014010　内蒙古包头，内蒙古科技大学包头医学院第一附属医院介入治疗科；014010　内蒙古包头，内蒙古科技大学包头医学院研究生院
    2. 014010　内蒙古包头，内蒙古科技大学包头医学院第一附属医院介入治疗科
  • 收稿日期:2019-04-26 出版日期:2019-08-01
  • 通信作者: 穆永旭

Clinical effect of superselective renal artery embolization in treatment of hematuria with renal cancer

Xiaoyu Wang1, Changsheng Wu2, Ruiqiang Yan2, Lei Zhang2, Haiyan Liu2, Yongxu Mu2,†()   

  1. 1. Department of Interventional Therapy, the First Affiliated Hospital, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China; Graduate School of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China
    2. Department of Interventional Therapy, the First Affiliated Hospital, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China
  • Received:2019-04-26 Published:2019-08-01
  • Corresponding author: Yongxu Mu
  • About author:
    Corresponding author: Mu Yongxu, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王晓雨, 吴常生, 闫瑞强, 张磊, 刘海艳, 穆永旭. 超选择性肾动脉栓塞术治疗肾癌性血尿的效果观察[J]. 中华介入放射学电子杂志, 2019, 07(03): 202-205.

Xiaoyu Wang, Changsheng Wu, Ruiqiang Yan, Lei Zhang, Haiyan Liu, Yongxu Mu. Clinical effect of superselective renal artery embolization in treatment of hematuria with renal cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2019, 07(03): 202-205.

目的：

评价超选择性肾动脉栓塞术治疗肾癌性血尿的临床效果。

方法：

回顾性分析2015年1月至2018年1月内蒙古科技大学包头医学院第一附属医院介入治疗科收治的肾癌性血尿患者39例，男22例，女17例。患者经辅助检查均诊断为肾癌性血尿，均接受超选择性肾动脉栓塞术。术后第2、7、14、21天留取患者血液及尿液样本，行血常规及尿常规化验。

结果：

39例患者均采用超液态碘油+明胶海绵微粒+明胶海绵颗粒栓塞，均一次栓塞成功，成功率达100%。其中，21例患者术后12 h肉眼血尿消失，18例术后24 h肉眼血尿消失。术后第2、7、14、21天，血红细胞数（RBC）、血红蛋白（Hb）、血细胞比容（HCT）水平均高于术前，尿RBC低于术前，差异均有统计学意义（P<0.01）。39例患者行栓塞术后均出现不同程度的栓塞综合征，临床表现为恶心、呕吐、发热及腰背胀痛等症状，经对症治疗2~5 d后消失。38例术后随访3~12个月，无一例发生异位栓塞、急性肾功能衰竭、肾坏死、肾脓肿等并发症。

结论：

超选择性肾动脉栓塞术治疗肾癌可以起到终止血尿的作用，且有微创、安全可靠、并发症少等优点。

关键词: 肾动脉栓塞术, 肾癌, 血尿
Objective:

To investigate the clinical effect of superselective renal artery embolization in treatment of hematuria with renal cancer.

Methods:

Retrospective analysis on 39 cases (22 males and 17 females) of hematuria with renal cancer treated in our hospital from January 2015 to January 2018 were selected. All patients were diagnosed as renal cell carcinoma hematuria by auxiliary examination and underwent superselective renal artery embolization. Blood and urine samples were collected on the 2nd, 7th, 14th and 21st postoperative day for routine blood and urine tests.

Results:

Thirty-nine patients were embolized with super liquid iodine oil + gelatin sponge particles. All of them were successfully embolized with a success rate of 100%. Among them, 21 patients had gross hematuria disappeared after 12 hours and 18 patients had gross hematuria eared after 24 hours after embolization. On the 2nd, 7th, 14th and 21st postoperative day, the levels of red blood cell count (RBC) , hemoglobin (Hb) and hematocrit (HCT) were higher than those before surgery, and the urine RBC was lower than that before surgery with statistically significant differences (P<0.01) . All the 39 patients had embolism syndrome after embolization. The clinical manifestations of nausea, vomiting, fever and low back pain were disappeared after symptomatic treatment for 2 to 5 days. 38 patients were followed up for 3 to 12 months. No complications such as ectopic embolization, acute renal failure, renal necrosis or renal abscess occurred.

Conclusions:

Superselective renal artery embolization can terminate hematuria in patients with renal cell carcinoma, and has the advantages of minimally invasive, safety and reliability, and fewer complications.

Key words: Renal artery embolization, Renal cancer, Hematuria
图1 典型病例1（男性，72岁，肾透明细胞癌，肉眼血尿）行超选择性肾动脉栓塞术治疗前后
图2 典型病例2（男性，56岁，肾透明细胞癌，肉眼血尿）行超选择性肾动脉栓塞术治疗前后
表1 39例患者手术前后的血、尿常规变化情况（n=39，±s）
组别 血RBC（×1012/L） Hb（g/L） HCT 尿RBC（个/μL）
术前 2.42±0.52 75.80±16.98 0.28±0.05 301.50±156.93
术后2 d 2.85±0.60 99.60±8.66 0.30±0.19 176.50±92.35
术后7 d 3.29±0.53 132.60±4.30 0.40±0.12 17.30±7.01
术后14 d 4.08±0.45 133.30±10.78 0.42±0.27 9.80±5.03
术后21 d 4.09±0.83 130.50±26.25 0.48±0.41 14.50±2.58
F值 20.579 41.458 36.826 25.806
P值 <0.001 <0.001 <0.001 <0.001
[1]
Sauk S, Zuckerman DA. Renal artery embolization[J]. Semin Intervent Radiol，2011，28(4): 396-406.
[2]
Ginat DT, Saad WE, Turba UC. Transcatheter renal artery embolization for management of renal and adrenal tumors[J]. Tech Vasc Interv Radiol，2010，13(2): 75-88.
[3]
纪东华，王峰，郎志谨.肾癌术前肾动脉栓塞及化疗性栓塞的疗效评价[J].介入放射学杂志，2002，11(1): 34-36.
[4]
Dixon S, Tapping CR, Chuah PS，et al. Successful fibroid embolization of pelvic and inferior mesenteric artery collaterals after previous uterine artery embolization[J]. Acta Radiol，2012，53(3): 292-295.
[5]
张荣远，马鸣.后腹腔镜肾癌根治术治疗局限性肾透明细胞癌临床分析[J].济宁医学院学报，2013，36(6): 408-409,414.
[6]
Badalato GM, Kates M, Wisnivesky JP，et al. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma（RCC）in the USA: a propensity scoring approach[J]. BJU Int，2012，109(10): 1457-1462.
[7]
Kim JM, Song PH, Kim HT，et al. Comparison of partial and radical nephrectomy for pT1b renal cell carcinoma[J]. Korean J Urol，2010，51(9): 596-600.
[8]
李金贵，胡自力.肾动脉介入栓塞在肾癌治疗中的应用[J].重庆医学，2007，36(11): 1100-1103.
[9]
顾克峰，潘峰，韩庆涛，等.CT引导下经皮穿刺射频消融补救性治疗晚期肾癌[J].中华介入放射学电子杂志，2014，2(3):45-48.
[10]
Maxwell NJ, Saleem Amer N, Rogers E，et al. Renal artery embolisation in the palliative treatment of renal carcinoma[J]. Br J Radiol，2007，80(950): 96-102.
[11]
Schwartz MJ, Smith EB, Trost DW，et al. Renal artery embolization: clinical indications and experience from over 100 cases[J]. BJU Int，2007，99(4): 881-886.
[12]
官彬，廖先国，文鹏程，等.肾癌外科根治性切除术前经动脉插管栓塞的临床价值[J].重庆医学，2015，44(22): 3072-3075.
[1] 杨春亭, 毛云华, 罗云, 刘博皓. 孤立肾合并肾混合性上皮间质肿瘤一例报告并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 407-409.
[2] 阿地力·克然木, 瓦斯里江·瓦哈甫, 邢念增. 肾癌伴静脉瘤栓的外科治疗进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 472-475.
[3] 努尔艾力·排尔哈提, 展昭兴, 王令令, 张古田, 朱新胜. 肾癌合并静脉癌栓的诊疗进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 459-462,471.
[4] 马涛, 叶春伟, 李卓衡, 杨晓芳, 庄浩, 郑玮玮, 李志鹏. 超选择性肾动脉栓塞治疗儿童重度闭合性多处肾碎裂伤一例并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 360-363,380.
[5] 张瑞敏, 于杰, 于晓玲. 早期肾细胞癌的影像引导消融治疗[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 381-384.
[6] 郝晓东, 李忠, 尹海军, 郑硕, 王磊, 王晓伟, 韩志辉. 输尿管息肉导致巨大肾积脓一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(03): 280-281.
[7] 谭智勇, 黄曦, 张贵福, 王海峰, 左毅刚, 王剑松. 原发性右输尿管鳞状细胞癌一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(03): 276-277.
[8] 刘和谦, 陶凌松, 王家伟, 陈弋生, 邹滨, 沈旭东. 肾蒂血管处理新策略对缩短后腹腔镜下肾癌根治术学习曲线的正面作用[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 147-150.
[9] 佟凯军, 刘大振, 汤坤龙, 杨长海. 后腹腔镜下肾部分切除与根治性肾切除治疗T1期肾癌的疗效分析[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 142-146.
[10] 王宝, 吴大鹏, 段中琪, 顾浩.
后腹腔镜肾部分切除术与肾癌根治术治疗复杂性T1b期肾肿瘤的比较 
#br#
[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 137-141.
[11] 杨宏林, 胡开松, 冯常福, 谢光强. 腹腔镜肾部分切除术与根治性切除术治疗T2a期肾癌比较研究及三年随访总结[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(02): 133-136.
[12] 刘晓梅, 张露, 刘旭, 梁蝶. 巨噬细胞迁移抑制因子靶向miR-127-3p对人肾癌细胞生物学行为的影响[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 76-83.
[13] 程莉, 章晓良. 血尿酸和胱抑素C与糖尿病视网膜病变患者合并糖尿病肾病的关系及影响因素[J]. 中华肾病研究电子杂志, 2023, 12(04): 194-199.
[14] 王丽霞, 马丽娟, 张宏文. 再看儿童孤立性镜下血尿的常见病因[J]. 中华临床医师杂志(电子版), 2023, 17(02): 112-116.
[15] 廖安琪, 王玫, 廖远泉. 达格列净诱发糖尿病患者血尿发生的临床诊断特征[J]. 中华诊断学电子杂志, 2023, 11(03): 169-172.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号